Traders work on the floor of the New York Stock Exchange near the Goldman Sachs stall July 16, 2010. REUTERS/Brendan McDermidBanks are self-regulating in advance of new financial reforms. Are recent moves by Goldman Sachs and JPMorgan “smoke and mirrors” or a way to subtly shift the form of impending regulation? *View analysis *View Q&A on Wall Street reform*Full coverage of regulatory news

“Unlocking the potential of Genzyme’s experimental multiple sclerosis drug Campath could be key to prying a higher price for the U.S. biotech from Sanofi-Aventis,” writes Lewis Krauskopf and Ben Hirschler. *View analysis *View WSJ blog

General Electric is building up its industrial business with a $3 billion bid for Dresser Inc. The deal announcement came the same day as oilfield services company Wellstream rejected GE’s takeover approach. *View article

Children’s apparel retailer Gymboree is exploring a sale of the company, sources say.  Lisa Lee at Dow Jones Investment Banker takes a look at why the company is so attractive to private equity firms. *View article